ASPEN PHAR.UN.ADR /1 O.N. Cash Flow Reinvestment Rate
ASPEN PHAR.UN.ADR /1 O.N. cash flow reinvestment rate. ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Cash Flow Reinvestment Rate of 0.98x as of June 2025, reinvesting €5.05 Billion (capex €5.05 Billion ) from operating cash flow of €5.16 Billion. See ASPEN PHAR.UN.ADR /1 O.N. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ASPEN PHAR.UN.ADR /1 O.N. (2022–2025)
Cash flow reinvestment rate of ASPEN PHAR.UN.ADR /1 O.N. from 2022 to 2025. Historical reinvestment intensity for ASPEN PHAR.UN.ADR /1 O.N. across 4 annual periods. Explore debt repayment capacity of ASPEN PHAR.UN.ADR /1 O.N. to assess how comfortably operating cash covers total debt obligations.
ASPEN PHAR.UN.ADR /1 O.N. Cash Flow Reinvestment Rate by Year (2022–2025)
ASPEN PHAR.UN.ADR /1 O.N. cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for ASPEN PHAR.UN.ADR /1 O.N.. For the full cash flow conversion analysis, see LDZU cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | €5.05 Billion | €5.16 Billion | €5.05 Billion | ▲ +10.2% |
| 2024 | 0.89x | €5.54 Billion | €6.22 Billion | €5.54 Billion | ▲ +54.3% |
| 2023 | 0.58x | €3.18 Billion | €5.52 Billion | €3.18 Billion | ▲ +11.1% |
| 2022 | 0.52x | €2.79 Billion | €5.37 Billion | €2.70 Billion | — |